Annual Revenue Increase of 16% Year Over Year MENLO PARK, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its…
MENLO PARK, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) — In a release issued earlier today under the same headline by Pacific Biosciences of California, Inc. (NASDAQ: PACB), please note that…
MENLO PARK, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Fourth Quarter 2019 Financial Results…
SAN DIEGO & MENLO PARK, Calif.–(BUSINESS WIRE)–Jan. 2, 2020– Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger…
MENLO PARK, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company’) today announced financial results for its third quarter ended September 30, 2019….
MENLO PARK, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that more…
SOLVE-RD Program Will Sequence More Than 500 Human Genomes With SMRT Sequencing MENLO PARK, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider…
MENLO PARK, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2019. On April…
Service Provider Adds Two More Sequel II Systems to Meet Growing Demand for Long-Read Sequencing Data MENLO PARK, Calif., August 6, 2019 — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading…
Identification of Pathogenic Structural Variants with SMRT Sequencing Improves Solve Rate for Rare and Mendelian Diseases MENLO PARK, Calif., June 13, 2019 (GLOBE NEWSWIRE) — While DNA sequencing tools have…
MENLO PARK, Calif., May 03, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its first quarter ended March 31, 2019, as attached….
New system is ideally suited for comprehensive variant detection, large genome de novo assembly, human structural variant characterization, whole transcriptome analysis, and more MENLO PARK, Calif., April 24, 2019 (GLOBE…
In a retrospective study, Anthony Nolan Research Institute found SMRT® Sequencing identified superior HLA matches, which are critical in determining successful transplant outcomes MENLO PARK, Calif., April 02, 2019 (GLOBE…
Customers to Present Results from a Range of Market Areas Including Human Biomedical, Evolutionary Biology, and AgBio; Company to Present New Methods for Single-Cell Isoform Sequencing and Low-Input DNA Protocol…
MENLO PARK, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its fourth quarter and year ended December 31, 2018,…
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.